Impel Pharmaceuticals Inc.
IMPL · NASDAQ
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$13,814 | -$7,357 | -$30,067 | -$23,041 |
| Dep. & Amort. | $635 | -$57 | $272 | $306 |
| Deferred Tax | -$2,551 | -$11,540 | $0 | $0 |
| Stock-Based Comp. | $1,067 | $1,099 | $1,319 | $1,252 |
| Change in WC | -$5,416 | -$4,026 | -$1,093 | $1 |
| Other Non-Cash | $3,555 | $1,441 | $5,426 | $3,496 |
| Operating Cash Flow | -$16,524 | -$20,440 | -$24,143 | -$17,986 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$957 | $132 | -$1,046 | -$1,012 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$957 | $132 | -$1,046 | -$1,012 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | -$79 |
| Stock Repurch. | $0 | $0 | $0 | -$79 |
| Dividends Paid | $0 | $0 | $0 | -$79 |
| Other Fin. Act. | $0 | $5 | $0 | -$79 |
| Financing Cash Flow | $7,060 | $5 | $0 | -$79 |
| Forex Effect | $11,488 | $21,402 | $0 | $0 |
| Net Chg. in Cash | -$10,421 | -$20,303 | -$25,189 | -$19,077 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $15,162 | $35,465 | $60,654 | $79,731 |
| End Cash | $4,741 | $15,162 | $35,465 | $60,654 |
| Free Cash Flow | -$17,481 | -$20,308 | -$25,189 | -$18,998 |